Trial Profile
Clinical and translational study of targeted Vascular Endothelial growth Factor receptor combined with chemotherapy in the treatment of metastatic ascites of gastric Cancer
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 23 Jul 2018
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Rivoceranib (Primary)
- Indications Adenocarcinoma; Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 23 Jul 2018 New trial record